(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202112 | 202012 | % Var | 202112 | 202012 | % Var | 202103 | 202003 | % Var | |
| Sales | 3086.10 | 2529.70 | 21.99 | 8405.30 | 7255.10 | 15.85 | 9872.60 | 8900.60 | 10.92 |
| Other Income | 30.10 | 97.20 | -69.03 | 283.50 | 344.20 | -17.64 | 407.30 | 858.20 | -52.54 |
| PBIDT | 180.90 | 16.60 | 989.76 | 400.80 | -815.00 | -149.18 | -969.70 | -901.20 | 7.60 |
| Interest | 792.20 | 492.00 | 61.02 | 1838.50 | 1547.80 | 18.78 | 2002.40 | 2201.70 | -9.05 |
| PBDT | -611.30 | -475.40 | 28.59 | -1437.70 | -3787.60 | -62.04 | -4396.90 | -3102.90 | 41.70 |
| Depreciation | 428.60 | 427.20 | 0.33 | 1280.50 | 1317.70 | -2.82 | 1840.80 | 1733.90 | 6.17 |
| PBT | -1039.90 | -902.60 | 15.21 | -2718.20 | -5105.30 | -46.76 | -6237.70 | -4836.80 | 28.96 |
| TAX | -368.70 | -215.90 | 70.77 | -873.40 | -1655.40 | -47.24 | -2317.30 | -1580.00 | 46.66 |
| Deferred Tax | -368.70 | 5.70 | -6568.42 | -651.80 | -571.00 | 14.15 | -949.30 | -1108.90 | -14.39 |
| PAT | -671.20 | -686.70 | -2.26 | -1844.80 | -3449.90 | -46.53 | -3920.40 | -3256.80 | 20.38 |
| Equity | 554.10 | 553.90 | 0.04 | 554.10 | 553.90 | 0.04 | 553.90 | 553.70 | 0.04 |
| PBIDTM(%) | 5.86 | 0.66 | 793.29 | 4.77 | -11.23 | -142.45 | -9.82 | -10.13 | -2.99 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.40 |
| Dr. Reddys Lab | 1279.70 |
| Cipla | 1304.70 |
| Zydus Lifesciences | 956.65 |
| Lupin | 2245.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: